The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
09 06 2021
Historique:
received: 27 04 2021
revised: 31 05 2021
accepted: 02 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 19 1 2022
Statut: epublish

Résumé

The current pandemic has brought a renewed appreciation for the critical importance of vaccines for the promotion of both individual and public health. Influenza vaccines have been our primary tool for infection control to prevent seasonal epidemics and pandemics such as the 2009 H1N1 influenza A virus pandemic. Certain high-risk populations, including the elderly, people with obesity, and individuals with comorbidities such as type 2 diabetes mellitus, are more susceptible to increased disease severity and decreased vaccine efficacy. High-risk populations have unique microenvironments and immune responses that contribute to increased vulnerability for influenza infections. This review focuses on these differences as we investigate the variations in immune responses to influenza vaccination. In order to develop better influenza vaccines, it is critical to understand how to improve responses in our ever-growing high-risk populations.

Identifiants

pubmed: 34207924
pii: v13061109
doi: 10.3390/v13061109
pmc: PMC8228336
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Influenza Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI140766
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : 75N93019C0052
Organisme : National Institute of Allergy and Infectious Diseases
ID : HHSN27220140006C
Organisme : National Institute of Allergy and Infectious Diseases
ID : R01AI140766

Références

Nat Rev Immunol. 2004 May;4(5):371-9
pubmed: 15122202
Obesity (Silver Spring). 2020 Sep;28(9):1631-1636
pubmed: 32779401
Cell. 2015 Jul 2;162(1):160-9
pubmed: 26140596
Sci Rep. 2017 Jul 26;7(1):6619
pubmed: 28747790
Metabolism. 2017 Jul;72:120-143
pubmed: 28641779
J Infect Dis. 2018 Jul 2;218(3):347-354
pubmed: 29506129
Vet J. 2012 Mar;191(3):292-8
pubmed: 21592831
Nutrition. 2021 Jul-Aug;87-88:111191
pubmed: 33744641
J Physiol. 2016 Jun 15;594(12):3187-207
pubmed: 26926488
Obesity (Silver Spring). 2013 Nov;21(11):2377-86
pubmed: 23512822
Vaccine. 2017 Jan 23;35(4):513-520
pubmed: 28024956
Nat Commun. 2019 Jul 26;10(1):3338
pubmed: 31350391
Diabetes Care. 2020 Jul;43(7):e72-e74
pubmed: 32409499
J Immunol. 2011 Dec 15;187(12):6208-16
pubmed: 22075699
Front Immunol. 2019 May 10;10:1071
pubmed: 31134099
Diabetes Care. 2010 Jul;33(7):1491-3
pubmed: 20587722
mBio. 2021 Feb 16;12(1):
pubmed: 33593972
PLoS One. 2018 Apr 13;13(4):e0195313
pubmed: 29652910
Nat Rev Drug Discov. 2004 Apr;3(4):340-51
pubmed: 15060529
Adv Nutr. 2016 Jan 15;7(1):66-75
pubmed: 26773015
Clin Microbiol Rev. 2019 Mar 13;32(2):
pubmed: 30867162
Mol Med Rep. 2018 Nov;18(5):4197-4212
pubmed: 30221719
Vaccine. 2006 Feb 20;24(8):1159-69
pubmed: 16213065
Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670
pubmed: 29297746
Int J Obes (Lond). 2012 Aug;36(8):1072-7
pubmed: 22024641
N Engl J Med. 2019 Dec 19;381(25):2440-2450
pubmed: 31851800
J Immunol. 2016 Nov 1;197(9):3650-3661
pubmed: 27683748
mBio. 2020 Mar 24;11(2):
pubmed: 32209691
Lancet Infect Dis. 2021 Feb;21(2):e26-e35
pubmed: 33125914
Antioxid Redox Signal. 2018 Jul 20;29(3):257-274
pubmed: 28891325
Expert Rev Vaccines. 2020 May;19(5):445-453
pubmed: 32516066
Sci Immunol. 2018 Aug 17;3(26):
pubmed: 30120121
J Infect Dis. 2019 Apr 8;219(Suppl_1):S30-S37
pubmed: 30715376
Ann N Y Acad Sci. 2010 Jan;1183:211-21
pubmed: 20146717
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
J Immunol. 2010 Mar 15;184(6):3127-33
pubmed: 20173021
Infez Med. 2016 Jun 1;24(2):123-30
pubmed: 27367322
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Biochim Biophys Acta. 2014 Mar;1842(3):446-62
pubmed: 23707515
PLoS Pathog. 2019 Dec 19;15(12):e1008109
pubmed: 31856206
Front Immunol. 2018 May 22;9:1071
pubmed: 29872429
Vaccine. 2021 Mar 4;:
pubmed: 33678455
Vaccine. 2017 May 15;35(21):2775-2780
pubmed: 28431815
Cell Immunol. 2020 Feb;348:103994
pubmed: 31831137
Cold Spring Harb Perspect Med. 2020 Dec 1;10(12):
pubmed: 31871227
Expert Rev Vaccines. 2019 Oct;18(10):1043-1051
pubmed: 31575308
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Nat Rev Dis Primers. 2018 Jun 28;4(1):3
pubmed: 29955068
Clin Microbiol Rev. 2013 Jul;26(3):476-92
pubmed: 23824369
Gerontology. 2012;58(1):15-23
pubmed: 21135534
ISRN Endocrinol. 2011;2011:980105
pubmed: 22363894
Dis Model Mech. 2009 May-Jun;2(5-6):231-7
pubmed: 19407331
Obesity (Silver Spring). 2016 Mar;24(3):615-25
pubmed: 26857091
Diabetes. 2007 Jun;56(6):1517-26
pubmed: 17389330
Lancet Infect Dis. 2007 Oct;7(10):658-66
pubmed: 17897608
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10172-10177
pubmed: 28874545
Diabetes Res Clin Pract. 2008 Apr;80(1):8-15
pubmed: 18291552
Mediators Inflamm. 2019 May 9;2019:5481725
pubmed: 31210749
J Ambul Care Manage. 2021 Jan/Mar;44(1):71-75
pubmed: 33165121
Obes Res Clin Pract. 2019 Sep - Oct;13(5):419-429
pubmed: 31542241
Interdiscip Top Gerontol Geriatr. 2020;43:86-97
pubmed: 32305981
Ann Intern Med. 2013 Dec 3;159(11):758-69
pubmed: 24297192
J Immunol. 2017 Jun 15;198(12):4738-4752
pubmed: 28500069
J Virol. 2020 Aug 31;94(18):
pubmed: 32661141
J Clin Invest. 2007 Sep;117(9):2621-37
pubmed: 17717599
Cell Physiol Biochem. 2016;38(3):1257-66
pubmed: 26982979
Vitam Horm. 2005;71:345-72
pubmed: 16112274
Nat Rev Endocrinol. 2011 Nov 08;8(4):228-36
pubmed: 22064493
Cell. 2018 Apr 5;173(2):417-429.e10
pubmed: 29625056
Adv Nutr. 2019 Jan 1;10(suppl_1):S4-S9
pubmed: 30721956
Mediators Inflamm. 2010;2010:568343
pubmed: 20368778
J Virol. 2020 Dec 22;95(2):
pubmed: 33115871
Obes Facts. 2017;10(4):284-307
pubmed: 28738325
J Infect Dis. 2014 Jul 15;209 Suppl 3:S114-9
pubmed: 24966191
Vaccine. 2014 Feb 7;32(7):881-7
pubmed: 24360890
mBio. 2020 Jan 21;11(1):
pubmed: 31964741
Front Immunol. 2019 May 24;10:1140
pubmed: 31178867
Diabetes. 2012 Sep;61(9):2238-47
pubmed: 22596049
Vaccine. 2017 May 9;35(20):2694-2700
pubmed: 28392139
Curr Opin Immunol. 2018 Aug;53:124-129
pubmed: 29753885
Int J Obes (Lond). 2017 Sep;41(9):1324-1330
pubmed: 28584297
Clin Infect Dis. 2021 May 4;72(9):e206-e214
pubmed: 32674114
PLoS Pathog. 2014 Jan;10(1):e1003875
pubmed: 24465206
Clin Exp Immunol. 2019 Aug;197(2):205-213
pubmed: 31251396
Lancet. 2020 May 16;395(10236):1544-1545
pubmed: 32380044
Autoimmunity. 2006 Mar;39(2):137-41
pubmed: 16698670
J Intern Med. 2018 Nov;284(5):492-504
pubmed: 29923291
Nature. 2008 Sep 25;455(7212):532-6
pubmed: 18716625
Immun Ageing. 2010 Jun 14;7:7
pubmed: 20546588
BMC Obes. 2016 May 03;3:24
pubmed: 27200179
Med Mal Infect. 2008 Dec;38(12):648-57
pubmed: 18986787
Hum Vaccin Immunother. 2014;10(5):1181-6
pubmed: 24614530
mBio. 2016 Aug 02;7(4):
pubmed: 27486196
Cell Immunol. 2020 Feb;348:103998
pubmed: 31733824
Front Immunol. 2018 Mar 23;9:600
pubmed: 29628926
J Immunol. 2009 May 15;182(10):6444-51
pubmed: 19414798
J Lipid Res. 2019 Oct;60(10):1648-1684
pubmed: 31209153
Hum Vaccin Immunother. 2017 Sep 2;13(9):2041-2047
pubmed: 28700268
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Eur J Immunol. 2010 Feb;40(2):366-77
pubmed: 19946883
Nephrology (Carlton). 2008 Dec;13(6):487-91
pubmed: 18331434
J Clin Invest. 2011 Jun;121(6):2111-7
pubmed: 21633179
Clin Exp Immunol. 2003 Jul;133(1):11-9
pubmed: 12823272
mBio. 2020 Mar 3;11(2):
pubmed: 32127459
Pharmacol Ther. 2019 May;197:153-178
pubmed: 30703416

Auteurs

Kristin B Wiggins (KB)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 308105, USA.

Maria A Smith (MA)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 308105, USA.

Stacey Schultz-Cherry (S)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 308105, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH